Dynamics of mitral regurgitation during nitroglycerin therapy: A Doppler echocardiographic study

Seven patients with decompensated chronic heart failure and functional mitral regurgitation were studied before and during administration of nitroglycerin at a mean dose of 42 μg/min (range 20 to 90 μg/min). Forward aortic flow obtained by pulsed Doppler increased significantly from 35 ± 8 to 45 ± 9 ml/beat (p < 0.001) and correlated well with the cardiac output measured by thermodilution technique (r = 0.8). Whereas regurgitant mitral volume calculated from the difference between echocardiographic total stroke volume and forward aortic flow decreased significantly from 19 ± 9 to 3 ± 3 ml/beat (p < 0.001), peak velocity of mitral regurgitant flow increased from 4.1 ± 0.9 to 4.4 ± 1.0 m/sec (p < 0.05). The decrease in effective mitral regurgitation area derived from a modified Gorlin formula average 80%. Accordingly, in patients with decompensated chronic heart failure and functional mitral regurgitation, nitroglycerin decreases mitral regurgitant area substantially, and thus almost abolishes mitral regurgitation despite an increase in systolic pressure gradient between left ventricle and atrium. Moreover, the increase in forward flow can be entirely accounted for by the reduction in mitral regurgitant flow.